Published in

Dove Press, OncoTargets and Therapy, (Volume 12), p. 1413-1421, 2019

DOI: 10.2147/ott.s189438

Links

Tools

Export citation

Search in Google Scholar

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO